U.S. flag

An official website of the United States government

NM_147127.5(EVC2):c.1845C>T (p.Thr615=) AND not provided

Germline classification:
Benign (3 submissions)
Last evaluated:
Aug 9, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001697762.18

Allele description [Variation Report for NM_147127.5(EVC2):c.1845C>T (p.Thr615=)]

NM_147127.5(EVC2):c.1845C>T (p.Thr615=)

Gene:
EVC2:EvC ciliary complex subunit 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
4p16.2
Genomic location:
Preferred name:
NM_147127.5(EVC2):c.1845C>T (p.Thr615=)
HGVS:
  • NC_000004.12:g.5628600G>A
  • NG_015821.1:g.85949C>T
  • NM_001166136.2:c.1605C>T
  • NM_147127.5:c.1845C>TMANE SELECT
  • NP_001159608.1:p.Thr535=
  • NP_667338.3:p.Thr615=
  • NC_000004.11:g.5630327G>A
  • NM_147127.4:c.1845C>T
Links:
dbSNP: rs112747818
NCBI 1000 Genomes Browser:
rs112747818
Molecular consequence:
  • NM_001166136.2:c.1605C>T - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_147127.5:c.1845C>T - synonymous variant - [Sequence Ontology: SO:0001819]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000531140GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Benign
(Apr 18, 2019)
germlineclinical testing

Citation Link,

SCV004147597CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Benign
(Aug 1, 2023)
germlineclinical testing

Citation Link,

SCV004563342ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process 2024)
Benign
(Aug 9, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000531140.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV004147597.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

EVC2: BP4, BP7, BS1, BS2

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV004563342.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 8, 2024